SERPINE1 and thrombotic disease: Given that inhibition of PAI‐1 augments the activities of the endogenous plasminogen activators, PAI‐1 has been recognized as a potential therapeutic target for fibrinolytic treatment of thrombotic disorders (Vaughan, 2011).